The two studies were quite comprehensive. We know that Auricle shows promise in reducing the actual decibel level for a significant percentage of participants. However, it's important to note that these participants did not receive the placebo sound-only treatment first, which could influence the results. Based on the findings, I would expect that over 50% of people with tinnitus—particularly those able to manipulate sound through various facial movements—may experience relief in a clinical setting. That said, real-world outcomes might differ, as audiologists and patients may not adhere as strictly to the treatment protocols as the study participants did.We won't know whether the device will be a success or a disappointment until it's either released or canceled.
I don't fault Susan Shore. This was a university-funded study without major corporate backing. The FDA approval process, along with rolling out devices and training audiologists, will take time. Unlike a multinational drug company with billions—or even millions—of dollars at their disposal, they have limited resources.